The flavonoid silymarin and one of its structural components, silibinin, are substances with documented hepatoprotective properties. Their mechanisms of action are still poorly understood. However ...

Patients were treated with silymarin 420 mg/day or with placebo for 4 weeks. At the end of the study period, mean AST and ALT levels diminished by 30.1% and 40.8%, respectively, in patients ...